These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26359221)

  • 1. Metformin: risk-benefit profile with a focus on cancer.
    Provinciali N; Lazzeroni M; Cazzaniga M; Gorlero F; Dunn BK; DeCensi A
    Expert Opin Drug Saf; 2015 Oct; 14(10):1573-85. PubMed ID: 26359221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risks from diabetes therapies: evaluating the evidence.
    Li C; Kong D
    Pharmacol Ther; 2014 Oct; 144(1):71-81. PubMed ID: 24844968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing old drugs to chemoprevention: the case of metformin.
    Heckman-Stoddard BM; Gandini S; Puntoni M; Dunn BK; DeCensi A; Szabo E
    Semin Oncol; 2016 Feb; 43(1):123-133. PubMed ID: 26970131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
    Ladeiras-Lopes R; Fontes-Carvalho R; Bettencourt N; Sampaio F; Gama V; Leite-Moreira A
    Expert Opin Ther Targets; 2015 Jul; 19(7):869-77. PubMed ID: 25762117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning metformin for cancer prevention and treatment.
    Quinn BJ; Kitagawa H; Memmott RM; Gills JJ; Dennis PA
    Trends Endocrinol Metab; 2013 Sep; 24(9):469-80. PubMed ID: 23773243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
    Gallagher EJ; LeRoith D
    Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy.
    Koritzinsky M
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):454-64. PubMed ID: 26383681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects.
    Emami Riedmaier A; Fisel P; Nies AT; Schaeffeler E; Schwab M
    Trends Pharmacol Sci; 2013 Feb; 34(2):126-35. PubMed ID: 23277337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk.
    Gao R; Yang T; Xu W
    Expert Opin Investig Drugs; 2017 Jul; 26(7):853-864. PubMed ID: 28541801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
    Goodwin PJ; Stambolic V
    Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
    McFarland MS; Cripps R
    Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin, an old drug, brings a new era to cancer therapy.
    He H; Ke R; Lin H; Ying Y; Liu D; Luo Z
    Cancer J; 2015; 21(2):70-4. PubMed ID: 25815846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
    Campagnoli C; Pasanisi P; Abbà C; Ambroggio S; Biglia N; Brucato T; Colombero R; Danese S; Donadio M; Venturelli E; Zito G; Berrino F
    Clin Breast Cancer; 2012 Jun; 12(3):175-82. PubMed ID: 22607767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the use of metformin: can treating diabetes prevent breast cancer?
    Hatoum D; McGowan EM
    Biomed Res Int; 2015; 2015():548436. PubMed ID: 25866793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.